Cell Culture Technology– category –
-
AGC Biologics Secures Multi-Million Dollar Commercial Manufacturing Deal for Yokohama Facility Ahead of 2027 Opening
히트뉴스 (HITNews) South Korea Overview AGC Biologics has signed a multi-year commercial manufacturing contract with an undisclosed global biopharmaceutical company for its new Yokohama facility, reserving approximately half of its mamma... -
Samsung Biologics Expands CDMO Reach with 60,000L GSK Facility Acquisition and Strategic PolyPeptide Group Buyout
Samsung Biologics South Korea Overview Samsung Biologics significantly bolstered its CDMO capabilities by acquiring a 60,000-liter GSK facility in Maryland, boosting total capacity to 845,000 liters, and agreeing to acquire PolyPeptide G... -
Chemically Defined Media Accelerates Biopharmaceutical Manufacturing with Enhanced Consistency and Regulatory Compliance
CASRAI Unknown Overview The biopharmaceutical industry is rapidly adopting Chemically Defined Media (CDM) to significantly improve cell culture consistency and regulatory compliance by eliminating undefined biological components. CDM ens... -
Cell Culture Technology Weekly Report August 16, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 16, 2026 (PDF) — Download Weekly Report August 16, 2026 (PDF) — DownloadDownload 🎙 Podcast August 16, ... -
Bioseon Unveils Proof-Driven Operating Guides for Autonomous Biologics Manufacturing, Supporting CDMOs and Biopharma with Live Titer & CQA Control via Soft Sensors and Digital Twins
Bioseon Unknown Overview Bioseon has released 'Proof-Driven Operating Guides' for autonomous biologics manufacturing. These guides focus on live titer and critical quality attribute (CQA) control utilizing soft sensors, Process Analytica... -
PMC Research Paper: High-Fidelity Machine Learning Models Predict Antibacterial Effects of Cerium Oxide Nanoparticles Across Bacterial Strains, Optimizing Nanobiotechnology and Antimicrobial Strategies
PMC Unknown Overview A research paper published in PMC applied advanced AI frameworks, including Convolutional Neural Networks (CNN) and Multi-layer Perceptron Artificial Neural Networks (MLP-ANN), to model bacterial cell concentration i... -
Era of AI-Driven Biocatalyst Design: Advances in High-Throughput Sequencing, Modeling, and Machine Learning Revolutionize Enzyme Engineering
(Scientific journal/review) Unknown Overview A new review discusses the evolution of enzyme engineering from classical strategies to AI-driven biocatalyst design. Advancements in high-throughput sequencing, modeling, and machine learning... -
Cultivated Meat Regulatory Complexity: FDA’s Proposed Mandatory GRAS Notification Rule Poised to Delay Market Entry
Petfood Industry USA Overview An article in Petfood Industry highlights that regulatory complexity presents a significant challenge for the market introduction of cultivated meat products. Specifically, the FDA's proposed mandatory GRAS ... -
Endress+Hauser Boosts Single-Use Bioprocessing with Innovative Proline Promass U 500 Coriolis Flowmeter, Integrating Reusable Units with Disposable Sensors for Enhanced Flexibility
Endress+Hauser Switzerland Overview Endress+Hauser announced the Proline Promass U 500 Coriolis flowmeter as the latest innovation in single-use technology for bioprocessing. This groundbreaking technology combines a reusable base unit w... -
US Federal Approval for Cultivated Meat Advances: FDA and USDA Permit Sale of Cell-Cultivated Chicken, Contributing to Reduced Environmental Impact and Enhanced Food Supply
(Facebook post) USA Overview In the U.S., federal safety approvals for cultivated meat have advanced, with the FDA and USDA permitting the sale of specific cell-cultivated chicken products. This move highlights potential benefits like re...
